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Abstract: Neuraxial analgesia is widely accepted as the most effective and the least depressant 
method of providing pain relief in labor. Over the last several decades neuraxial labor analgesia 
techniques and medications have progressed to the point now where they provide high quality 
pain relief with minimal side effects to both the mother and the fetus while maximizing the 
maternal autonomy possible for the parturient receiving neuraxial analgesia. The introduction 
of the combined spinal epidural technique for labor has allowed for the rapid onset of analgesia 
with minimal motor blockade, therefore allowing the comfortable parturient to ambulate. 
Patient-controlled epidural analgesia techniques have evolved to allow for more flexible analgesia 
that is tailored to the individual needs of the parturient and effective throughout the different 
phases of labor. Computer integrated systems have been studied to provide seamless analgesia 
from induction of neuraxial block to delivery. New adjuvant drugs that improve the effective-
ness of neuraxial labor analgesia while decreasing the side effects that may occur due to high 
dose of a single drug are likely to be added to future labor analgesia practice. Bupivacaine still 
remains a popular choice of local anesthetic for labor analgesia. New local anesthetics with less 
cardiotoxicity have been introduced, but their cost effectiveness in the current labor analgesia 
practice has been questioned.
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Introduction
Labor is one of the most painful situations a human can experience. It was rated more 
painful than cancer pain and as painful as amputation of a digit without anesthesia.1
Labor pain when unrelieved can have adverse effects on the course of labor as well 
as on the fetal wellbeing.2 Although various techniques such as inhaled nitrous oxide, 
parenteral opioids, and alternative therapies (including acupuncture, hydrotherapy, or 
trancutaneous electrical nerve stimulation) have been employed to lessen the pain and 
trauma of a painful labor, it is widely accepted that the neuraxial analgesia is the most 
effective and least depressant form of intrapartum analgesia currently available. Women 
in pain don’t need an “indication” for pain relief in labor. According to the American 
Society of Anesthesiology (ASA) “in the absence of a medical contraindication, maternal 
request is a sufficient medical indication for pain relief during labor” (Statement on 
pain relief during labor, Oct 17, 2007). In addition, they state that neuraxial analgesia 
should not be withheld on the basis of achieving an arbitrary cervical dilatation.
Epidural analgesia has been used to alleviate labor pain for almost 50 years.
Historically, labor analgesia was administered as a single shot injection of large 
volume of local anesthetic through the epidural needle. This required repeated epidural International Journal of Women’s Health 2009:1 32
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procedures since analgesia was short lived. Not only this 
method was unsatisfactory there were several maternal 
deaths due to unrecognized intravascular and intrathecal 
administrations.3 Subsequently, heightened awareness and 
widespread adoption of safer anesthetic practice resulted 
in several changes in the technique for administration of 
labor epidural analgesia. These include use of epinephrine 
containing test dose and fractionation of epidural injections. 
With the advent of epidural catheters, repeated administration 
of supplemental analgesia was facilitated without the need 
for repeated epidural needle insertion or direct injection of 
medications through the needle. Because of its minimal motor 
block compared to sensory block, bupivacaine became the 
popular choice for labor analgesia. However, the high con-
centration of local anesthetic that was used before late 1980s 
led to high incidence of motor blockade and other unwanted 
effects such as maternal hypotension.
Addition of neuraxial opioids permitted reduction in the 
concentration of bupivacaine from 0.5% to as low as 0.065% 
while maintaining effective analgesia, and minimizing 
potential adverse effects on the progress of labor and lower 
extremity motor block. Combined spinal epidural and/or 
epidural with low dose local anesthesia may allow women to 
ambulate while in labor (termed in the lay press “the walking 
epidural”). New levo isomer local anesthetics, ropivacaine 
and levobupivacaine have been introduced in recent years, 
which may be less cardiotoxic than bupivacaine.
There is no question that neuraxial labor analgesia is the 
most effective pain relief method in labor. However, there are 
situations where neuraxial methods are not possible because of 
contraindications (such as maternal coagulopathy, hypovolemia, 
generalized sepsis) or due to patient refusal. Opioids are the 
most commonly used parenteral medication for labor analgesia. 
Unfortunately, for many parturients opioids only provide mild 
to moderate analgesia in safe doses that is those that do not 
result in maternal sedation, respiratory depression or neonatal 
depression. Remifentanil is a potent, ultra-short acting opioid 
with a rapid onset and offset of action regardless of the dura-
tion of administration. It is unique in that it is hydrolyzed 
by non-specific blood and tissue esterases and has no active 
metabolites.4 Remifentanil is shown to produce effective labor 
analgesia with minimal maternal or neonatal sequale.5 Although 
it crosses the placenta, it appears to be rapidly metabolized 
and/or redistributed in the fetal circulation. Currently, we are 
developing a system that senses uterine contractions and times 
the delivery of remifentanil to occur approximately one minute 
prior to the contraction, so that the maximum analgesia effect 
falls within the peak contraction period.
This review focuses on current methods and the recent 
progress of neuraxial labor analgesia techniques.
Initiation of labor analgesia
Combined spinal-epidural (CSe)
The CSE technique is gaining popularity in obstetric practice 
to provide optimal analgesia for parturients because it offers 
the possibility of combining the rapid onset of subarachnoid 
analgesia with the flexibility of continuous epidural 
analgesia. The duration of spinal analgesia is between 2 and 
3 hours, depending on which agent or agents are chosen. The 
duration of spinal analgesia, however, was shown to decrease 
when administered to a woman in advanced labor.6 The 
original description of spinal analgesia involved sufentanil 
or fentanyl, but the addition of isobaric bupivacaine to the 
opioid produces greater density of sensory blockade with 
longer duration while still minimizing motor blockade.7 
Originally, 25 µg of fentanyl or 10 µg of sufentanil with 
2.5 mg of bupivacaine was advocated, but more recent studies 
have suggested using smaller doses of opioid combined with 
smaller doses of local anesthetic.8 The ED50 of intrathecal 
fentanyl for this purpose has been shown to be 14 ± 1 µg and 
for sufentanil 4.1 ± 0.3 µg.10 Many clinicians now routinely 
use 5 µg of sufentanil or 15 µg of fentanyl intrathecally. 
Fentanyl is widely used as an intrathecal agent for labor 
analgesia because of its low cost, rapid onset and profound 
analgesia without motor blockade. Intrathecal fentanyl 
provides a long enough duration of analgesia for an epidural 
infusion started immediately after intrathecal injection to 
reach therapeutic analgesic levels, thus creating a ‘seamless’ 
transition from spinal to epidural. Serious maternal side 
effects of intrathecal fentanyl are infrequent.
Recent studies have suggested that ropivacaine and 
levobupiacaine can be substituted for intrathecal bupiva-
caine to provide labor analgesia.11,12 Teoh et al reported that 
patients who received hyperbaric bupivacaine had a longer 
median duration of analgesia (122 min; range 80–210 min) 
than those who received plain bupivacaine (95 min; range 
75–125 min) (p  0.01). The hyperbaric group also had a 
more limited dermatomal spread (T8 versus T4) while side 
effect profile was similar in both groups.13
Advantages of CSE for labor
Confirmation of epidural needle 
placement
The appearance of CSF in the hub of the spinal needle during 
the spinal portion of the CSE confirms the correct placement International Journal of Women’s Health 2009:1 33
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of epidural needle. This is especially important in obese 
patients with increased skin to epidural space distance or 
those with difficult anatomic landmarks.
Higher success rate with the block
When compared with conventional epidural analgesia for 
labor, the incidence of overall failure, accidental intravascular 
placement of epidural catheter, inadequate epidural analgesia, 
and catheter replacements were shown to be significantly 
lower in patients receiving CSE analgesia.14 This difference 
may be due to the option to confirm questionable epidural 
needle location by successful spinal injection.15
Ambulatory labor analgesia
When CSE is performed with subarachnoid opioids (with or 
without small analgesic doses of local anesthetics) there is 
minimal motor blockade, therefore allowing the parturient 
to ambulate. The desire for mobility during labor further 
increased the interest in CSE technique. Although it was 
formerly thought that maternal ambulation could speed the 
progress of labor, to date the evidence has not been conclu-
sive.16,17 According to the 2001 obstetric anesthesia work 
force survey, almost all hospitals allowed ambulation during 
spinal opioids administration, but much smaller percentage 
of patients actually ambulated.18
In clinical practice the degree of motor blockade is often 
assessed using the Bromage/modified Bromage scale.19 To 
enable ambulation in labor, all muscle groups innervated by 
the L5-S1 nerve roots should have normal or “near normal” 
power (Bromage score 0).
CSe: more rapid cervical dilation?
Tsen et al reported that CSE analgesia, when adminis-
tered to nulliparous parturients in early labor, resulted in 
significantly more rapid cervical dilatation compared with 
standard epidural analgesia.20 This finding was validated 
by Wong et al who similarly found that spinal opioids 
were associated with a faster dilatation.21 The mechanism 
of rapid cervical dilatation with CSE is unknown. It may 
be related to reduction in local anesthetic exposure when 
compared with epidural analgesia, or more likely due to 
rapid reduction in maternal catecholamines secondary to 
immediate pain relief with CSE analgesia. In vivo, it has 
been suggested that epidural bupivacaine may directly 
slow uterine activity.22 Clinical studies also support the 
proposition that maternal epinephrine may be a tocolytic 
and its reduction may enhance uterine contractions.2 This 
mechanism may be related to reports of uterine hypertonia 
and fetal bradycardia that infrequently occur following 
CSE labor analgesia
Despite these advantages, the obstetric anesthesia work-
force survey reported that less than 10% of all hospitals use 
CSE in the year 2001.18 Although CSE seems to be a straight- 
forward technique, there still remain some concerns.
Concerns of CSE for labor
All neuraxial techniques may be associated with complaints 
of back pain and neurologic complications, but most 
neurologic complications are associated with pregnancy and 
delivery, not the anesthetic.23,24
Dural puncture and post dural puncture 
headache (PDPH)
The incidence of PDPH after CSE technique is controver-
sial. It might be argued that the intentional dural puncture 
involved in the CSE technique would increase the risk of 
PDPH in obstetric patients compared with those receiving 
epidural analgesia alone. However, the use of small-gauge 
atraumatic pencil point spinal needles, such as Whitacre, Pen-
can, Sprotte, and Gertie Marx, greatly reduce the incidence 
of PDPH in patients receiving CSE.25 Norris and coworkers26 
reported that the patients who received only epidural anal-
gesia were more likely to suffer accidental dural puncture 
(two-fold increase; epidural vs CSE = 4.2%:1.7%). These 
investigators offered two possible explanations for this result. 
First, they most often choose CSE for women who are in 
early labor and reserve epidural analgesia for patients in the 
more painful active phase of labor. Therefore, the patients 
in the epidural group may have been more likely to move 
during the procedure, and thus cause a ‘wet tap’. Second, 
during CSE if one is uncertain of the location of the epidural 
needle, the spinal needle can be inserted to look for CSF or 
closeness to dura.
Administration of intrathecal opioids has been shown 
to decrease the incidence of PDPH.27 Subsequent infusion 
of an epidural local anesthetic infusion also may help to 
decrease the incidence of PDPH (possible tamponade effect?) 
following CSE.
Table 1 Modified bromage score
Score Description
0 No paralysis, raises extended leg, full flexion of knee and ankle
1 Inability to raise extended leg, able to move knee
2 Inability to flex knee, able to flex ankle
3 Inability to move lower limbInternational Journal of Women’s Health 2009:1 34
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Risk of catheter migration
Although CSE block with the needle-through-needle 
technique has recently become increasingly popular, the risk 
of epidural catheter migration through the dural hole made 
by the spinal needle has been a concern to many. Holmstrom 
et al28 performed a percutaneous rigid epiduroscopy study to 
assess the risk of catheter migration during CSE and found 
that it was impossible to force an 18-G epidural catheter 
through the dural hole after a single dural puncture made by 
a 25 G spinal needle. After multiple (five) dural punctures 
with the spinal needle, the epidural catheter penetrated the 
perforated dura in 1 in 20 cases. For those clinicians who 
remain concerned about intrathecal catheter migration, spe-
cial epidural needles with back holes to reduce this risk are 
currently available from several manufacturers.
Increased drug leakage through  
the dural puncture
Leighton and collegues29 reported that following CSE, a dose 
of epidural local anesthetic will produce a higher dermatomal 
level than expected, presumably due to subarachnoid flux 
of the drug. This effect however was quite small and when 
used for labor analgesia, unless the dura is breeched with the 
epidural needle or a large bolus volume is administered, flux 
should not be clinically significant.
Infectious complications
Theoretically, CSE could be associated with an increased risk 
of meningitis compared with epidural alone because the dura 
(protective barrier for CNS) is punctured deliberately during 
CSE and then a foreign body (an epidural catheter), is placed 
nearby. Contamination of the subarachnoid space may occur 
from bleeding due to needle trauma in a bacteremic patient 
or from failure of aseptic technique. Phillips and coworkers30 
reported no cases of meningitis after a prospective review of 
10,440 cases of spinal anesthesia in patients undergoing obstet-
ric and urological operations, which are known to be associ-
ated with perioperative bacteremia. However, case reports of 
meningitis following CSE appeared in the journals beginning 
mid 1990s.30–32 There was also a case of aseptic meningitis 
associated with the spinal component of the CSE technique.33
Headache and neck pain or neck stiffness in a patient who 
recently had spinal anesthesia is often attributed to PDPH. 
One case report34 highlighted the danger associated with 
missed diagnosis. Her condition deteriorated, and meningitis 
was not considered as a diagnosis until it was too late and the 
patient subsequently died in an intensive care unit.
Contamination of CSF  
with metal particles
It has been alleged that during the needle-through-needle 
(NTN) CSE technique, tiny metal particles abraded by the 
spinal needle from the inner edge of the Tuohy needle may 
be introduced into the epidural or spinal compartment.35 
In order to examine this concern, Holst and collegues36 
simulated the NTN technique in an in-vitro model. They 
reported no increased alloy components detected in the rinse 
solution after either twofold or fivefold puncture compared 
with the control measurements. No traces of abrasion could 
be detected by electron microscopy on the inner ground edge 
of the Tuohy needle either.
Fetal bradycardia
The cause of fetal bradycardia after CSE remains unclear, but 
it may be related to an acute reduction in circulating maternal 
catecholamine levels after the quick onset of analgesia. In 
addition, it has been postulated that an imbalance between 
epinephrine and norepinephrine levels cause unopposed 
alpha-adrenoceptor effects on uterine tone and decreases 
uterine blood flow. However, preliminary reports suggest that 
there may be no alteration in uteroplacental blood flow.37 The 
reported incidence of prolonged decelerations ranges from 
3.9% to 12%, and some required emergency cesarean deliv-
ery. However, it seems the doses of intrathecal opioids used 
by these practitioners were relatively high by current standards 
(ranging from 50 µg of fentanyl to 7.5 µg to 10 µg of sufen-
tanil).38 When lower doses of intrathecal opioids were used, 
CSE analgesia was shown not to be associated with adverse 
outcome for the fetus. A retrospective study39 involving 1240 
patients who received neuraxial labor analgesia (mostly CSE), 
and 1140 patients who received systemic medications or no 
analgesia, demonstrated no significant difference in the rate of 
cesarean delivery with rates of 1.3% and 1.4%, respectively. 
That study also reported no emergency cesarean deliveries for 
acute “fetal distress” in the absence of obstetric indications up 
to 90 minutes after intrathecal sufentanil administration.
Untested epidural catheter
The function of the epidural catheter inserted with the CSE 
technique is uncertain until after the duration spinal analgesia. 
Although there are concerns about the unknown location of 
the catheter if an emergency procedure is required within 
one to two hours of CSE placement,40 this issue seems to 
have been addressed. Epidural catheters inserted via needle 
through needle technique were demonstrated to have a higher 
probability of being in the epidural space as compared to International Journal of Women’s Health 2009:1 35
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catheters inserted in the stand-alone epidural technique.41 The 
author of one study suggested ‘laboring women at risk for 
operative intervention can safely receive CSE analgesia’.
CSe technique appears cumbersome  
and time consuming
Newer CSE trays have helped to eliminate preparation time. 
It is believed that in experienced hands the entire procedure 
should not take longer than a few minutes.42
Side effects of intrathecal opioids-
Itching, nausea and vomiting, hypotension, and respiratory 
depression have all been reported following appropriate 
doses of spinal fentanyl or sufentanil. A recent report of a 
dramatic overdose of intrathecal opioid for labor (45 mcg 
sufentanil as part of a CSE) demonstrated intense pruritus 
as well as difficulty swallowing, but incomplete pain relief 
for the second stage of labor.43
Itching
Itching (facial or generalized) commonly occurs after admin-
istration of intrathecal opioids. The reported incidence of 
this side effect after intrathecal sufentanil is between 33% 
and 95%.44 The incidence may approach 100% after intra-
thecal morphine.45The mechanism of itching appears to be 
complex. One theory suggests that facial itching is mediated 
by a specific opioid effect in the medullary dorsal horn.46 
Activation of the serotonergic system is also considered as 
an important factor in the pathogenesis of intrathecal opi-
oid-induced pruritus.47 Most often this itching is mild and 
transient and only rarely requires treatment. Studies that ask 
patients specifically about itching report a higher incidence.44 
The addition of intrathecal local anesthetic has been shown 
to reduce the risk of opioid-induced itching.48
Nausea and vomiting
Like itching, nausea and vomiting may also occur more 
often with CSE than conventional epidural analgesia.25 
However, the incidence of this side effect is relatively low 
(2.4%–3.2%).
Hypotension
Hypotension (SBP  90 mmHg) is well recognized after 
epidural local anesthetics, and studies have reported a 
17% to 28% incidence during epidural labor analgesia.49 
Hypotension has also been reported in up to 14% of 
parturients receiving either intrathecal fentanyl/morphine50 
or intrathecal sufentanil44 for labor analgesia. The mechanism 
of hypotension after intrathecal opioids is unclear. A weak 
local anesthetic effect44 or an action on opioid receptors 
located in the preganglionic sympathetic nerve fibers51 
has been suggested. However, it has been reported that in 
humans sympathetic nerve activity remains unchanged after 
intrathecal morphine.52
Norris et al reported a similar effect on systolic blood 
pressure by both labor epidural and CSE.26 He reported 7.9% 
incidence of hypotension after intrathecal sufentanil, a much 
lower incidence than the other studies. Some agree that the 
hypotension may be simply related to pain relief.
Respiratory depression
Although exceedingly rare in parturients receiving lipid soluble 
neuraxial opioids, it has been reported that neuraxial opioids 
may be associated with a clinically significant respiratory 
depression which may even lead to fatal consequences.53 Non-
obstetric studies report 0.01% to 7% incidence of respiratory 
depression after neuraxial opioids.53,54 Lipophilic opioids such 
as fentanyl and sufentanil, which are commonly administered 
intrathecally during CSE, may rarely cause early-onset 
respiratory depression typically within 30 min. This is likely 
due to the significant vascular uptake55 via subarachnoid 
vascular plexuses or rostral spread via cerebrospinal fluid.56 
Due to the risk of respiratory depression, the ASA Task Force 
recommends that after neuraxial lipophilic opioids continual 
respiratory monitoring should be performed for a minimum 
of 2 hour after bolus administration or discontinuation of 
the infusion.53,57
Comparison of CSe with conventional 
epidural technique for labor analgesia
Many studies have compared CSE with straight epidural 
analgesia technique. Norris et al58 performed a prospective, 
quasi-randomized clinical trial in a large number of women 
(2183 laboring women) comparing needle-through-needle 
CSE and epidural labor analgesia. The primary outcome 
studied was mode of delivery (spontaneous vaginal, opera-
tive vaginal, or cesarean). Important secondary outcomes 
included neonatal condition (as measured by Apgar score and 
umbilical artery blood gas values) and anesthetic complica-
tions and success. They found no difference in obstetric or 
neonatal outcome that could be explained by the choice of 
anesthetic technique. There was no increased incidence of 
positional headache due to intentional dural puncture with the 
27 gauge (pencil point) spinal needle in the CSE group. Later, 
Miro et al also confirmed the safety of CSE, with similar 
findings, in a retrospective study involving 6497 cases.59International Journal of Women’s Health 2009:1 36
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Test dose controversy
The issue of whether a test dose is needed prior to initiating 
an epidural infusion for labor with ultra-dilute local anesthetic 
has been questioned.60,61 Currently, many anesthesiologists 
avoid the “classic” test dose (1.5% lidocaine with epinephrine 
1:200,000) and argue that the unintentional IV administration 
of an ultra-dilute solution of local anesthetic such as less than 
0.1% bupivacaine with fentanyl, could not possibly harm a 
patient. After several hours, the infusion itself becomes a test; 
if the epidural catheter is intravascular, the patient should 
have no pain relief; if the catheter is subarachnoid, a solid 
motor block would develop. If the patient remains comfort-
able and without a motor block, a proper epidural catheter 
placement is highly probable. The test dose that contains 
concentrated local anesthetic and epinephrine can increase 
the motor block of the subsequent epidural and therefore 
reduce the possibility of walking.62
However, this argument fails to consider the patients 
who require an emergency cesarean delivery before the 
recognition of an intravascular catheter. Although infusions 
of ultra-dilute local anesthetics do not pose a serious threat, 
such is not true of concentrated local anesthetics used for 
operative delivery. Therefore, use of a test dose should be 
considered when administration of large doses of high con-
centration local anesthetic through the epidural catheter is 
required such as operative delivery.
Fluid preloading
It is the standard practice in many institutions to administer 
a fluid preload prior to initiation of neuraxial labor analgesia. 
Fluid preloading is thought to reduce hemodynamic changes, 
specifically hypotension, caused by labor epidural. Collins 
et al in 1978, showed that fluid preloading significantly 
reduces abnormalities in fetal heart rate (FHR) (34% to 
12%) and maternal hypotension (28% to 2%) during epidu-
ral analgesia.63 They excluded patients with preeclampsia 
and pre-existing hypertension. However, Collins original 
study used bupivacaine 0.375%, a concentration that is not 
commonly used in current practice, and probably the cause 
for significant hypotension. Recent investigators ques-
tions the relevance of fluid preloading in current epidural 
practice because they were not able to show a statistically 
significant increase in the incidence of maternal hypoten-
sion when intravenous preloading was omitted before labor 
epidural using a low concentration bupivacaine.64,65 A study 
by Kinsella et al also showed similar findings using a low 
concentration bupivacaine during labor epidural.66 However, 
new abnormalities in FHR tracing occurred in 11% and 30% 
of the preload and no preload groups, respectively. Although 
this did not reach statistical significance, it may be cause for 
concern. Is fluid loading beneficial to FHR tracing (fetus)? 
Cheek et al performed a study to observe the effects of 
intravenous fluid infusion on uterine activity during normal 
labor in women receiving epidural analgesia. There was a 
decrease in uterine activity after a one-liter fluid bolus, which 
returned to baseline over the next 20 minutes. There was no 
hypotension in the group that did not receive fluid preload. 
Epidural block has no effect on the uterine activity.67 The 
authors speculated that the mechanism of decreased uterine 
activity lie either in a release of atrial natriuretic peptide 
(ANP) after atrial distension with fluid bolus or due to release 
of vasoactive peptides by the uterine vascular endothelium. 
It is possible that reduced uterine activity from a fluid bolus 
cause the positive effects on the FHR tracing. Rham et al68 
reported a fall in the plasma oxytocin concentration one hour 
after initiation of labor epidural analgesia. He concluded that 
epidural analgesia may interfere with the release of plasma 
oxytocin, and may be one mechanism behind prolongation 
of labor. The epidural may, however, be one of many factors 
and is unlikely to be primarily related.
Fluid preloading may be beneficial prior to labor epidur-
als in situations where fetus is at increased risk. However, 
routine use of preload in current epidural practice is ques-
tionable and may lead to prolonged labor due to decreased 
uterine activity.
Maintenance of labor analgesia
Continuous epidural infusion
Currently, the most commonly used technique for mainte-
nance of labor analgesia is continuous epidural infusion, 
which avoids a number of problems that had been associ-
ated with intermittent bolus techniques, such as uneven 
analgesia and possible increased infection rate. With the 
advent of automated infusion pumps, continuous infusion 
of epidural medications via an indwelling catheter became 
possible. New forms of epidural analgesia use combina-
tions of opioid and lower concentration of local anesthetic 
which preserve maternal motor function and allow par-
turients to ambulate. The COMET study, a randomized 
controlled trial69 (Comparative Obstetric Mobile Epidural 
Trial) compared traditional epidural analgesia for labor 
using high concentration local anesthetics (bupivacaine 
0.25%) with two types of low dose techniques, namely CSE 
and continuous low dose infusion (bupivacaine 0.1% with 
fentanyl) in 1054 nulliparous women requesting epidural 
pain relief. The authors reported that the low-dose epidural International Journal of Women’s Health 2009:1 37
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analgesia resulted in significantly more vaginal deliveries 
than traditional technique. They estimated that almost one 
in four operative vaginal deliveries could be prevented by 
the introduction of low dose epidural analgesia. Cesarean 
delivery rates between traditional and low dose techniques 
did not differ. The quality of analgesia was the same with all 
methods, indicating that the benefit achieved by the low-dose 
techniques do not compromise pain relief. They concluded 
that “in relation to delivery outcome, continued routing use 
of traditional epidurals might not be justified”.
Automated intermittent bolus
The maintenance of labor analgesia after intrathecal induction 
with a CSE technique is commonly achieved with the use 
of a continuous epidural infusion, which is usually initiated 
prior to regression of spinal analgesia. A study by Sebastian 
et al showed that employing a regimen of regularly sched-
uled automated intermittent boluses one could improve the 
analgesic function of the epidural catheter.70 Experimentally, 
it has been shown that the spread of an infusate from a multi-
orificed catheter is more extensive if regular boluses were 
used instead of a continuous infusion, despite a similar rate 
of discharge. Kaynar and Shankar71 demonstrated at low 
injection pressures the flow through a multi-orifice catheter 
is largest from the proximal hole and no flow occurred from 
the distal port. During bolus injection, the solution flowed 
through all the ports and caused wide spread of the solution. 
This wider spread probably contributes to better quality of 
the block in the intermittent bolus technique. In the future, 
infusion devices may become available to allow programmed 
boluses. Wong et al72 in a randomized, double-blind study, 
compared total bupivacaine consumption, need for supple-
mental epidural analgesia, quality of analgesia, and patient 
satisfaction in 158 multiparous term women who received 
programmed intermittent epidural boluses (PIEB) compared 
with continuous epidural infusion (CEI) for maintenance of 
labor analgesia. They reported that compared to CEI group 
in the PIEB, the median total bupivacaine dose per hour 
of analgesia was less, fewer manual rescue boluses were 
required, and satisfaction scores were higher. Labor pain, 
patient-controlled epidural analgesia (PCEA) requests, and 
delivered PCEA doses did not differ. They concluded “PIEB 
combined with PCEA provided similar analgesia, but with 
a smaller bupivacaine dose and better patient satisfaction 
compared with CEI with PCEA for maintenance of epidural 
analgesia”.
Previous studies also have shown that intermittent 
manual bolus injection has a dose-sparing effect on total 
local anesthetic consumption compared with CEI.73 Chua 
and Sia74 also observed that PIEB is a good alternative to 
CEI for the maintenance of epidural analgesia after CSE. 
They observed that the PIEB prolonged the duration and 
quality of analgesia.
Patient-controlled epidural analgesia 
(PCeA)
First described for use in labor by Gambling et al75 in 1988, 
PCEA allows the parturient to self-administer intermittent 
boluses of epidural medication, thus providing flexibility 
to accommodate changing analgesic requirements as labor 
progresses. The anesthesiologist adjusts the PCEA program 
settings such as demand bolus, lockout interval, background 
infusion rate and hourly maximum rate for individual 
patients. PCEA allows better dose-demand matching as 
labor progresses, and therefore is shown to be associated 
with reduced total volume of local anesthetic requirements, 
especially in the first stage of labor.
In the classic study by Gambling75 the patients were ran-
domized to receive 0.125% bupivacaine as a (CIEA) continu-
ous infusion (12 mL/hour) or under PCEA setting (4ml basal, 
4 mL bolus as required up to 16 mL/hour). Patients in the 
PCEA received significantly less local anesthetic than those 
in the CIEA group, and appreciated control over their own 
pain relief with less reliance on medical staff. A significant 
reduction in hourly dose requirements, varying from 17% 
to 47%, has been shown by various studies when compared 
with continuous infusions.76–81 Anesthesiologist-delivered 
supplemental “top-ups” and anesthesia personal work load 
is also shown to be reduced when PCEA mode is used.82 
Although PCEA is claimed to have several advantages, 
according to the most recent obstetric anesthesia work force 
survey,18 only 18% to 35% of hospitals in the US employ 
PCEA. The reason for this low use in unclear, possibly due 
to unfamiliarity or equipment cost.
Gambling et al also performed a double-blind, prospective 
study79 to determine the optimal initial combination of bolus 
dose and lockout interval for PCEA. He compared 4 different 
bolus-only PCEA combinations with a CIEA group 
(8 mL/hour). Each group received 0.125% bupivacaine with 
1:400,000 epinephrine and fentanyl 2.5 µg/mL. This study 
was designed to answer 2 questions. (1) Does it matter which 
PCA dose variables are used to set up PCEA in labor? (2) Is 
PCEA, without a background infusion, as effective as CIEA? 
He reported, “There were no differences seen among four 
dosing programs chosen for PCEA in labor. Patients in each 
group experienced similar degrees of satisfactory pain relief, International Journal of Women’s Health 2009:1 38
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and this was comparable to the analgesia provided by constant 
infusion.” The bupivacaine and fentanyl consumption were 
less in PCEA groups than in the CIEA group.
Continuous epidural infusion (CeI)  
with PCeA
PCEA can be administered as demand dosing (DD) 
only mode or as continuous epidural infusion plus DD 
mode. Demand dosing involves a fixed amount of drug 
administered by the patient by pressing the PCA button 
without concomitant use of a continuous background 
infusion. With continuous infusion plus demand dosing, 
a continuous background infusion is prescribed and the 
patient can administer supplemental doses by pressing 
the PCA button. The role of the background infusion 
(CEI) in the PCEA setting seems to be still unclear in the 
literature. While some authors suggest that the CEI with 
PCEA increases drug consumption without an analgesia 
benefit,83,84 other studies have demonstrated reduced 
need for analgesia supplementation with CEI. Ferrante 
et al85 performed a study to determine whether there is 
any advantage for a background infusion during PCEA 
for labor and delivery. They randomized 60 nulliparous 
or parous women in labor at term to one of four groups 
to receive either continuous epidural infusion (CEI) or 
three PCEA groups in a double-blind fashion. All patients 
received 0.125% bupivacaine with 2 µg /mL of fentanyl 
through the PCA infuser. CEI group received the epidural 
infusion at 12 mL/hour. The three PCEA groups received 
either no background epidural infusion, or CEI at a rate 
of 3 mL/hour or 6 mL/hour. The findings of their study 
were as follows: The patients receiving fixed-rate CEI had 
a lower incidence of spontaneous delivery (p  0.04). All 
modes of PCEA provided equivalent pain scores, extent of 
sensory, degree of motor blockade, and cumulative hourly 
bupivacaine use. However DD only PCEA, and provision 
of a minimal background infusion (CEI 3 mL/hour) were 
associated with a trend towards increased necessity for 
physician administered supplemental bupivacaine, which 
may be difficult to quickly achieve in a busy obstetric 
unit. The group, CEI 6 mL/hour + DD PCEA received 
33% of its maximum hourly demand dose as a back-
ground infusion and the need for physician administered 
supplementation was minimal. Therefore, according to 
this study, administration of a modest proportion (33%) 
of the maximum hourly demand dose as a background 
infusion would appear optimal when PCEA is used for 
labor analgesia.
Computer-integrated patient-controlled 
epidural analgesia (CI-PCeA)
In a PCEA mode, the basal infusion (CEI) appears to play 
an increasingly important role as pain intensifies with the 
progress of labor or with the initiation of labor augmentation 
regimens. In order to achieve seamless analgesia (defined as 
one without breakthrough pain from induction of block to 
delivery), Sia and colleagues86 made a further improvement 
in the CEI-PCEA mode. He devised a program (based on a 
clinical algorithm) that converts an ordinary continuous infu-
sion pump to a PCEA pump. The pump analyses the patient’s 
needs in the previous hour (based on the PCEA needs) and 
automatically adjusts the basal infusion accordingly. There-
fore, the basal infusion rate would be automatically increased 
for a patient who makes more demands. They called this 
computer-integrated PCEA (CI-PCEA). In his pilot study, 
which compared CEI only to CI-PCEA, he demonstrated 
that CI- PCEA reduced the incidence of breakthrough pain. 
However, these authors were not able to demonstrate a 
difference in the hourly consumption of local anesthetics 
or patient satisfaction between the two groups. In a follow 
up study done by Lim et al the breakthrough pain requiring 
anesthetic supplementation was lower in the CI-PCEA group 
(15%–35%), but this difference was not statistically signifi-
cant. However, the CI-PCEA group reported significantly 
higher maternal satisfaction scores.87
New local anesthetics
Bupivacaine has been the standard local anesthetic for epi-
dural labor analgesia for many years. It has many advantages 
when used for labor analgesia; the quality of analgesia is high 
in relation to the degree of motor block, the duration is long, 
and it is generally not associated with tachyphylaxis, as seen 
with lidocaine.88 Unfortunately, a number of cases of toxic 
reactions and refractory cardiac arrests3 have been associ-
ated with bupivacaine, most involving obstetric patients, 
and 0.75% bupivacaine is now proscribed from obstetric 
practice. Animal studies87 have confirmed that bupivacine 
is more cardiotoxic than lidocaine, a mechanism relating 
to its action on the cardiac sodium channels. Lidocaine 
blocks channels in a fast-in-fast-out fashion. Bupivacaine 
was found to be a “fast-in, slow-out” agent. The reason for 
increased incidence of fatal systemic toxicity to bupivacaine 
in pregnancy may be due to many factors.90 These include: 
(1) more frequent use of bupivacaine for epidural blocks, 
especially in high concentrations prior to the late 1970s, (2) 
it is easier to accidentally puncture dilated epidural veins dur-
ing pregnancy (3) physiological changes of pregnancy makes International Journal of Women’s Health 2009:1 39
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them more susceptible to such reactions (4) resuscitation is 
more difficult in a parturient.
The appreciation of the cardiotoxicity of bupivacaine 
in the late 1970s led to two important changes: First, the 
heightened awareness, widespread adoption of safer anes-
thetic practice including test doses, fractionation of epidural 
injection, and use of dilute solutions by continuous infusion. 
Hawkins et al91 reported no maternal deaths due to bupi-
vacaine-induced cardiotoxicty in the analysis of maternal 
mortality during the period of 1979 to 1990. Second, is the 
development of newer local anesthetics with less intrinsic 
toxicity.
The two new local anesthetics, levobupivacaine and 
ropivacaine have been compared to bupivacaine and shown 
to provide very satisfactory labor analgesia with a possible 
reduced incidence of motor blockade and decreased cardio-
toxicity.
Animal models have confirmed the reduced systemic 
toxicity of these newer anesthetic agents. Santos and 
DeArmars92 performed an animal study to compare the sys-
temic toxicity of three local anesthetics (levobupivacaine, 
bupivacaine, and ropivacaine) and to determine whether 
pregnancy affect the systemic toxicity. They found that 
the doses required to produce convulsions were lower in 
the pregnant animals than in the non-pregnant for all three 
drugs. However, there were no significant differences in the 
doses required to produce more advanced manifestations 
of systemic toxicity such as circulatory collapse and apnea 
between pregnant and non-pregnant. The risk of toxicity was 
greatest with bupivacaine and least with ropivacaine. Human 
volunteer studies also confirm the reduced systemic toxic-
ity of ropivacaine.93 Both levobupivacaine and ropivacaine 
have been shown to have less arrythmogenic potential than 
bupivacaine, and therefore resuscitation seems to be more 
effective in cases of systemic toxicity.94,95
Bader et al96 compared the effect on motor function of 
ropivacaine and bupivacaine at equal concentrations using 
an isolated rabbit vagus nerve model. Their results showed 
that the depressant effect of bupivacaine was 16% greater 
on motor fibers compared to ropivacaine. Writer et al97 
performed a meta-analysis involving 403 laboring women 
who received either ropivacaine or bupivacaine 0.25% (equal 
strength) as intermittent bolus or continuous bolus for labor 
epidural analgesia. Their study showed that spontaneous 
deliveries occurred more frequently with ropivacaine that 
with bupivacaine (58% vs 49%; p  0.05), and instrumen-
tal deliveries were less frequent with ropivacaine (27% vs 
40%; p  0.01). The cesarean delivery rates, however, were 
similar between groups. The motor block was also shown 
to be lower in the ropivacaine group. However, their study 
has been criticized as not uniform in the design, results not 
homogenous, and therefore difficult to draw conclusions.98 
Dresner et al99 performed a randomized double blind 
comparison of 0.1% bupivacaine plus fentanyl 2 µg/mL vs 
0.2% ropivacaine (double strength) as continuous infusion 
for epidural labor analgesia. They found no difference in the 
motor block or mode of delivery between groups. The pain 
relief and satisfaction scores from midwives and patients 
were consistently better in the ropivacaine group, but this 
did not reach statistical significance. Although there seems 
to be a difference in the motor block between ropivacaine 
and bupivacaine at diluted concentrations (ie, 0.1%), this 
difference seems to disappear at higher concentrations (ie, 
0.25% or 0.5%).100–102
Most of the above comparisons seem to have assumed 
that the new local anesthetics (ropivacaine and levobupi-
vacine) are equipotent with bupivacaine. This seems to be 
true with levobupivacine but not with ropivacaine. Lyons 
et al103 compared the minimum local analgesic concen-
trations (MLAC) of levobupivacaine relative to racemic 
bupivacaine in a prospective, randomized, double-blind, 
sequential allocation study. They found the potency ratio 
to be almost equal (0.98) between levobupivacaine and 
bupivacaine. However, using up-down sequential allocation, 
Polley et al104 found the MLAC of bupivacaine to be 0.067% 
wt./volume (95% confidence interval [CI], 0.052–0.082), 
the MLAC of ropivacaine to be 0.111% wt./volume (95% 
CI 0.100–0.122, and the potency ratio between the two to 
be 0.6 (95% CI 0.49–0.74). Similarly, Capogna et al also 
found analgesic potency of ropivacaine to be 40% less than 
that of bupivacaine.105 Therefore, it has been argued that the 
modest motor sparing property (even systemic toxicity?) of 
ropivacaine noted in some studies may merely reflect the 
potency difference, and must be re-evaluated.96 However, a 
study by Dony et al found ropivacaine to be less toxic than 
bupivacaine even at an equipotent dose.106
The new local anesthetics are considerably more expen-
sive than racemic bupivacaine. The approximate incremental 
cost of substituting ropivacaine for bupivacaine for labor 
analgesia was calculated to be approximately US$12 per 
patient.107 With the widespread use of ultra-dilute epidural 
infusions of bupivacaine and CSE technique, it is very 
unlikely that systemic toxicity will be a problem during labor 
epidural analgesia. There seems to be no clinical justification 
to use more expensive local anesthetics such as ropivacaine 
in the current labor analgesia practice. Both laboratory International Journal of Women’s Health 2009:1 40
Ranasinghe and Birnbach Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
and clinical studies have failed to show that ropivacaine or 
levobupivacaine offers any advantage over bupivacine in 
terms of placental transfer and/or neonatal outcome.108–110
New adjuvant drugs
Adjuvant drugs are used to improve the effectiveness of 
neuraxial labor analgesia and decrease the side effects that 
may occur due to a high dose of a single drug. Neuraxial 
opioids are used routinely for this purpose. Recently, several 
studies have demonstrated the effectiveness of clonidine (an 
alpha-2 adrenergic agonist) and neostigmine (cholinester-
ase inhibitor) for labor analgesia or for post cesarean pain 
relief.111,112 Clonidine produces analgesia by binding to the 
alpha-2 adrenergic receptors in the dorsal horn of the spinal 
cord to inhibit the release of substance P. Neuraxial clonidine 
also increases acetylcholine levels in the cerebrospinal fluid. 
Neostgmine increases spinal acetylcholine by preventing its 
breakdown. Analgesia is produced when acetylcholine binds 
to the spinal cord receptors (muscarinic and nicotinic) and 
stimulates the nitric oxide synthesis.113
Intrathecal use of clonidine  
and neostigmine for labor
A small dose of intrathecal clonidine (15–30 µg) when 
combined with local anesthetics and opioids is shown to 
produce high quality, rapid onset prolonged labor analgesia 
but with sedation and hypotension.111 Therefore, maternal 
blood pressure must be carefully monitored and treated with 
ephedrine quickly. Owen et al showed that the duration of 
analgesia from intrathecal bupivacaine-fentanyl can be sig-
nificantly increased by the addition of clonidine 30 micg and 
neostigmine 10 micg.112 However, intrathecal neostigmine is 
associated with severe nausea that is unresponsive to standard 
medications.112
epidural use of clonidine and neostigmine 
for labor
Paech et al evaluated clonidine as a component of PCEA. 
He reported that the addition of clonidine (22–45 µg/hour) 
to bupivacaine (0.0625%) and fentanyl (2 µg/mL) produced 
better pain relief and reduced the need for PCEA boluses dur-
ing the first stage of labor.114 Maternal hypotension caused 
no fetal consequences when treated promptly. There was 
reduced motor block with clonidine due to the local anesthetic 
dose-sparing effect. Neostigmine, however, appears to relieve 
somatic pain better than visceral pain and also has a low 
lipid solubility. Higher doses are required to be effective in 
labor.115 Epidural clonidine 75 µg with neostigmine 750 µg 
was shown to be effective in initiating labor analgesia without 
motor or sympathetic block.116
Further studies are needed to evaluate the efficacy and the 
side effects of these adjuvant drugs before adding to labor 
analgesia practice.
Effect of epidural analgesia  
on labor outcomes
This has been a controversial topic for many years and several 
prospective, randomized trials have been published recently 
addressing this issue.117–119 The most recent article published 
by Wong et al21 concluded:
1.  Neuraxial analgesia with low concentration epidural 
infusions (bupivacaine 0.0625% with 2 micg/ml of 
fenatnyl or 0.125% bupivacaine) does not increase the risk 
of cesarean delivery or instrumental vaginal delivery.
2.  Neuraxial analgesia in early labor (4 cm dilatation) 
does not increase the rate of cesarean delivery. Compared 
to systemic analgesia, it provides better analgesia and 
shorter duration of labor.
Conclusion
The amount of labor pain experienced by a parturient is influ-
enced by many factors. These include oxytocin augmentation, 
presence of dysfunctional labor, duration and phase of labor, 
as well as various psychological and socio-cultural factors. 
The ideal labor analgesia should provide effective pain relief 
throughout the different phases of labor while tailored to 
the specific needs of the individual parturient. Over the past 
decades, neuraxial analgesia techniques and medications 
have evolved to allow for more flexible and effective anal-
gesia while reducing the density of motor blockade.
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